Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock ...
RenovoRx will present its findings from a pharmacokinetic and pharmacodynamic sub-study of the Company’s ongoing Phase III TIGeR-PaC clinical trial, led by Dr. Paula Novelli of the University of ...
Strong relational governance between technology vendors and sponsor–CRO teams is becoming a critical foundation for eCOA ...
The push for sustainable dentistry is here, but it's disconnected from the clinical and financial realities of our practices.
As we look to 2026, there's a bright future for well-governed healthcare information to advance artificial intelligence ...
Trinity Health Chief Health Informatics Officer Murielle Beene shares how health informaticists are approaching artificial ...
Waystar Holding Corp. (WAY) Presents at Barclays 23rd Annual Global Technology Conference Transcript
Barclays 23rd Annual Global Technology Conference December 10, 2025 6:40 PM ESTCompany ParticipantsMatthew Hawkins - CEO ...
We have worked many overnight shifts in the ED caring for a hallway full of admitted patients because there were no inpatient ...
JMIR Publications continues its commitment to high-impact analysis in its "News & Perspectives" section with a new article detailing how digital innovations are transforming the fight against ...
Several of Wall Street's savviest billionaire money managers purchased this stock during the September-ended quarter.
3don MSN
Early use of meds may lead to life-threatening conditions in preterm infants with heart defect
Babies born prematurely can have a number of complications at birth, simply because they are brought into the world before ...
The purpose of this commentary is to critically examine the CREST-2 results, discuss their implications for clinical decision-making for asymptomatic carotid artery disease, and guide clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results